Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.

Publication Title

Leukemia & lymphoma

Document Type

Article

Publication Date

1-1-2018

Keywords

Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological/adverse effects; Antineoplastic Agents, Immunological/therapeutic use; Combined Modality Therapy/methods; Female; Humans; Male; Middle Aged; Multiple Myeloma/drug therapy; Multiple Myeloma/pathology; Neoplasm Recurrence, Local; Nivolumab/adverse effects; Nivolumab/therapeutic use; Remission Induction; Treatment Outcome

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Specialty/Research Institute

Earle A. Chiles Research Institute

Link to Full Text

Providence Full Text

Share

COinS